Hantavax coin
Live on Solana

Crypto-Powered Virology. Funding the Cure for Andes Hantavirus.

Hantavax ($HANTAVAX) bridges decentralized finance with frontline medical research to engineer the world's first definitive vaccine against the Andes Orthohantavirus strain.

Price

$0.0000421

Market Cap

$4.2M

Liquidity

🔒 Locked

The Crisis

A Virus With No Cure

The Andes Orthohantavirus is the only hantavirus strain confirmed to transmit person-to-person. With fatality rates exceeding 35%, and zero commercially available vaccines in Western markets, the global window for intervention is narrowing. Hantavax exists to close that gap.

35% – 40%

Average Fatality Rate of Hantavirus Pulmonary Syndrome

0 Approved

Vaccines commercially available in Western markets for the Andes strain

100% Dedicated

Smart contract allocation directed to medical research grants and vaccine pipelines

How It Works

The Funding Mechanism

Every transaction fuels the mission. A transparent, immutable pipeline from market activity to medical breakthroughs.

STEP 01

Community Trades

Community buys and trades $HANTAVAX tokens on decentralized exchanges, building liquidity and grassroots funding momentum.

STEP 02

Automated Fund Allocation

Automated transaction fee mechanisms safely divert designated percentages into a multi-signature Medical Ecosystem Fund.

STEP 03

Research Deployment

Capital is deployed directly to independent virology laboratories and clinical research teams globally to bridge funding gaps.

Documentation

Hantavax Protocol V1 Whitepaper

Sections

Abstract & Epidemiology

Hantaviridae Taxonomy

ANDV belongs to family Hantaviridae, the only hantavirus with person-to-person transmission.

Gn/Gc Glycoprotein Targets

Viral glycoproteins Gn/Gc mediate host-cell attachment. Primary antigenic targets for vaccine design.

Transmission Dynamics

Andes virus spreads via respiratory droplets between humans, unlike other rodent-borne hantaviruses.

Roadmap

Ecosystem Roadmap

A phased approach modeled after clinical trial methodology.

Phase 1Active

Isolation

  • Token Fair Launch
  • Smart Contract Audit
  • Community Building
Phase 2Upcoming

Synthesis

  • First research donation tranche
  • DEX tracker listings
  • Independent lab partnerships
Phase 3Planned

Clinical Trial

  • Viral marketing campaigns
  • Tier-1 CEX listings
  • Endemic region awareness
Phase 4Vision

Full Immunity

  • Vaccine development funding
  • Open-source distribution tracking
  • Global health impact